Concurrent HDAC and mTORC1 Inhibition Attenuate Androgen Receptor and Hypoxia Signaling Associated with Alterations in MicroRNA Expression

Specific inhibitors towards Histone Deacetylases (HDACs) and Mammalian Target of Rapamycin Complex 1 (mTORC1) have been developed and demonstrate potential as treatments for patients with advanced and/or metastatic and castrate resistant prostate cancer (PCa). Further, deregulation of HDAC expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Leigh, Lehet, Kristin, Ramakrishnan, Swathi, Adelaiye, Remi, Miles, Kiersten M., Wang, Dan, Liu, Song, Atadja, Peter, Carducci, Michael A., Pili, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210144/
https://www.ncbi.nlm.nih.gov/pubmed/22087262
http://dx.doi.org/10.1371/journal.pone.0027178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210144/
https://www.ncbi.nlm.nih.gov/pubmed/22087262
http://dx.doi.org/10.1371/journal.pone.0027178

Ejemplares similares